HM Payson & Co’s Protolabs PRLB Stock Holding History

HM Payson & Co’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-120	Closed	-$4.68K	–	995
2023 Q4	$4.68K	Buy	+120	New	+$3.89K	﹤0.01%	869

Other funds holding PRLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

HM Payson & Co's PRLB Position: Q1 2024 in Review

HM Payson & Co sold out of Protolabs (PRLB) in Q1 2024, closing a stake of 120 shares — an estimated $4.68K sold.

HM Payson & Co first reported a position in PRLB in Q4 2023 and held it in 1 quarter. The position peaked at $4.68K in Q4 2023. 203 funds tracked by Wall St. Rank hold PRLB as of Q1 2024.

HM Payson & Co reported no remaining Protolabs position as of Q1 2024 after selling out during the quarter.
HM Payson & Co sold 120 Protolabs shares in Q1 2024, an estimated $4.68K.
HM Payson & Co first reported a position in Protolabs in Q4 2023 and held it in 1 quarter.
HM Payson & Co's Protolabs position peaked at $4.68K in Q4 2023.
203 funds tracked by Wall St. Rank held Protolabs as of Q1 2024.

Based on HM Payson & Co's 13F filing for Q1 2024, filed 20 Jun 2024.